Literature DB >> 5655478

Inhibition of monoamine oxidase in man by furazolidone.

W A Pettinger, F G Soyangco, J A Oates.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5655478     DOI: 10.1002/cpt196894442

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  13 in total

1.  The assessment of interactions in man between tyramine and viloxazine hydrochloride, an antidepressant drug.

Authors:  K Ghose; P Turner; I N Grant
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

2.  Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients.

Authors:  A Korn; H G Eichler; R Fischbach; S Gasic
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Inhibition of amine oxidases by nitrofuran derivatives: possible structure-activity relations and criteria of irreversibility.

Authors:  K Quiring; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

4.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  Inhibition of monoamine oxidase by furazolidone in the chicken: influence of the alimentary flora [proceedings].

Authors:  B H Ali; A L Bartlet
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

6.  Cardiocirculatory effects of Ro 11-2465, a selective 5-HT (serotonin) uptake inhibitor, in healthy volunteers.

Authors:  S Gasic; A Korn; L M Omer
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Inhibition of monoamine oxidase by furazolidone in the chicken and the influence of the alimentary flora thereon.

Authors:  B H Ali; A L Bartlet
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.

Authors:  A Martini; L Bonollo; F B Nicolis; R Sega; A Palermo; E Braibanti
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 9.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

10.  Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteers.

Authors:  P R Bieck; K H Antonin
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.